Blue Water Vaccines Inc. Contracts & Agreements
92 Contracts & Agreements
- Business Finance (25 contracts)
- Business Operations (9)
- Human Resources (30)
- Intellectual Property (9)
- Real Estate (1)
- Uncategorized (18)
- License Agreement, dated March 27, 2023, between Proteomedix and Laboratory Corporation of America Holdings (Filed With SEC on April 11, 2024)
- Amendment to Employment Agreement by and between Proteomedix and Christian Brhlmann (Filed With SEC on April 11, 2024)
- Amendment to Employment Agreement, dated October 16, 2020, by and between Proteomedix and Christian Brhlmann (Filed With SEC on April 11, 2024)
- Form of Employment Agreement with Christian Brhlmann (Filed With SEC on April 11, 2024)
- Amendment to Employment Agreement by and between Proteomedix and Ralph Schiess (Filed With SEC on April 11, 2024)
- Amendment to Employment Agreement, dated October 15, 2020, by and between Proteomedix and Ralph Schiess (Filed With SEC on April 11, 2024)
- Form of Employment Agreement with Ralph Schiess (Filed With SEC on April 11, 2024)
- Description of Registered Securities (Filed With SEC on April 11, 2024)
- Consulting Agreement, dated January 4, 2024 (Filed With SEC on February 12, 2024)
- Debenture, dated January 23, 2024 (Filed With SEC on January 29, 2024)
- Consulting Agreement, dated January 17, 2024, between the Company and The Aetos Group (Filed With SEC on January 19, 2024)
- Separation Agreement, dated January 17, 2024, between the Company and Erin Henderson (Filed With SEC on January 19, 2024)
- Form of Subscription Agreement, dated December 15, 2023, by and among Onconetix, Proteomedix, and the Investor (Filed With SEC on December 21, 2023)
- Form of Stockholder Support Agreement, dated December 15, 2023, by and among Onconetix, Proteomedix, and certain stockholders of Proteomedix (Filed With SEC on December 21, 2023)
- Form of Non-Competition and Non-Solicitation Agreement, dated as of December 15, 2023, by and among Onconetix and certain stockholders of Proteomedix (Filed With SEC on December 21, 2023)
- Form of Lock-Up Agreement, dated as of December 15, 2023, by and among Onconetix and certain stockholders of Proteomedix (Filed With SEC on December 21, 2023)
- Certificate of Designation of Series B Convertible Preferred Stock (Filed With SEC on December 21, 2023)
- Share Exchange Agreement, dated December 15, 2023, by and among Onconetix, Proteomedix AG, Thomas Meier and the Sellers (Filed With SEC on December 21, 2023)
- Exclusive Distribution Agreement, dated September 20, 2023, between the Company and Cardinal Health 105, LLC (Filed With SEC on November 17, 2023)
- Form of Amendment, dated October 5, 2023, to Asset Purchase Agreement, dated June 13, 2023, by and among WraSer, LLC, Xspire Pharma, LLC, Legacy-Xspire Holdings, LLC and Blue... (Filed With SEC on October 20, 2023)
- Employment Agreement, dated October 4, 2023, between the Company and Dr. Neil Campbell (Filed With SEC on October 10, 2023)
- Employment Agreement, dated October 4, 2023, between the Company and Bruce Harmon (Filed With SEC on October 10, 2023)
- Form of Indemnification Agreement (Filed With SEC on October 10, 2023)
- Amendment to Asset Purchase Agreement, dated as of September 29, 2023, by and between Blue Water Biotech, Inc. and Veru Inc (Filed With SEC on October 3, 2023)
- Form of Letter Agreement (Filed With SEC on August 3, 2023)
- Form of Inducement PIO (Filed With SEC on August 3, 2023)
- Form of Inducement Letter (Filed With SEC on August 1, 2023)
- Form of Inducement PIO (Filed With SEC on August 1, 2023)
- Management Services Agreement, dated June 13, 2023, by and among WraSer, LLC, Xspire Pharma, LLC, and Blue Water Biotech, Inc (Filed With SEC on June 14, 2023)
- Asset Purchase Agreement, dated June 13, 2023, by and among WraSer, LLC, Xspire Pharma, LLC, Legacy-Xspire Holdings, LLC and Blue Water Biotech, Inc (Filed With SEC on June 14, 2023)
- Co-Development Agreement, dated February 1, 2023, between the Company and AbVacc, Inc (Filed With SEC on May 12, 2023)
- Patent & Technology License Agreement, dated November 18, 2022, between the Company and the University of Texas Health Science Center at San Antonio (Filed With SEC on May 12, 2023)
- Form of Non-Competition and Non-Solicitation Agreement, dated as of April 19, 2023 (Filed With SEC on April 20, 2023)
- Asset Purchase Agreement, dated as of April 19, 2023, between Veru Inc. and Blue Water Vaccines Inc (Filed With SEC on April 20, 2023)
- At-the-Market Offering Agreement, dated March 29, 2023 (Filed With SEC on March 29, 2023)
- Settlement Agreement and Release, dated October 9, 2022, by and between the Registrant and Boustead Securities, LLC (Filed With SEC on November 14, 2022)
- Form of Registration Rights Agreement, dated as of August 9, 2022, by and among the Company and the Purchasers (Filed With SEC on August 11, 2022)
- Form of Securities Purchase Agreement, dated as of August 9, 2022, by and among the Company and the Purchasers (Filed With SEC on August 11, 2022)
- Form of Wainwright Warrants by and among the Company and H.C. Wainwright & Co., LLC (Filed With SEC on August 11, 2022)
- Form of Preferred Investment Options, by and among the Company and the holders (Filed With SEC on August 11, 2022)
- Form of Pre-Funded Common Stock Purchase Warrant, by and among the Company and the holders (Filed With SEC on August 11, 2022)
- Sponsored Research Agreement, effective as of June 30, 2022, by and between Blue Water Vaccines Inc. and Childrens Hospital Medical Center, d/b/a Cincinatti Childrens Hospital... (Filed With SEC on July 25, 2022)
- Amendment to Agreement for the Sponsorship of a Research Project, dated May 16, 2022 (Filed With SEC on June 1, 2022)
- Agreement for the Sponsorship of a Research Project, dated as of December 19, 2019, by and between Blue Water Vaccines Inc. and The Chancellor Masters and Scholars of the... (Filed With SEC on June 1, 2022)
- Amendment #1 to Exclusive License Agreement, dated as of May 11, 2022, by and between the Registrant and St. Jude Childrens Research Hospital, Inc (Filed With SEC on May 13, 2022)
- Amendment No. 1 to Project Addendum 2 to Master Services Agreement, dated as of April 20, 2022, by and between the Registrant and Ology Bioservices, Inc (Filed With SEC on May 13, 2022)
- Form of Registration Rights Agreement, dated as of April 13, 2022, by and among the Company and the Purchasers (Filed With SEC on April 19, 2022)
- Form of Securities Purchase Agreement, dated as of April 13, 2022, by and among the Company and the Purchasers (Filed With SEC on April 19, 2022)
- Form of Wainwright Warrants by and among the Company and H.C. Wainwright & Co., LLC (Filed With SEC on April 19, 2022)
- Form of Preferred Investment Options, by and among the Company and the holders (Filed With SEC on April 19, 2022)
- Form of Pre-Funded Common Stock Purchase Warrant, by and among the Company and the holders (Filed With SEC on April 19, 2022)
- Description of Registered Securities (Filed With SEC on March 31, 2022)
- Representatives Warrant (Filed With SEC on February 24, 2022)
- Underwriting Agreement (Filed With SEC on February 24, 2022)
- Form of Underwriting Agreement (Filed With SEC on February 8, 2022)
- Form of Representatives Warrant (Filed With SEC on February 8, 2022)
- Form of Warrant Agency Agreement (Filed With SEC on January 6, 2022)
- Form of Employment Agreement with Jon Garfield (Filed With SEC on January 6, 2022)
- Form of Employment Agreement with Erin Henderson (Filed With SEC on January 6, 2022)
- 2022 Equity Incentive Plan Form of Nonstatuory Stock Option Agreeement (Employee) (Filed With SEC on January 6, 2022)
- 2022 Equity Incentive Plan Form of Nonstatuory Stock Option Agreeement (Non-Employee Director) (Filed With SEC on January 6, 2022)
- 2022 Equity Incentive Plan Form of Nonstatuory Stock Option Agreeement (Consultant) (Filed With SEC on January 6, 2022)
- 2022 Equity Incentive Plan Form of Incentive Stock Option Agreement (Employee) (Filed With SEC on January 6, 2022)
- 2022 Equity Incentive Plan (Filed With SEC on January 6, 2022)
- Form of Warrant (Filed With SEC on January 6, 2022)
- Form of Underwriting Agreement (Filed With SEC on December 29, 2021)
- Form of Representatives Warrant (included in Exhibit 1.1) (Filed With SEC on December 29, 2021)
- Form of Warrant Agency Agreement (Filed With SEC on December 29, 2021)
- Form of Warrant (Filed With SEC on December 29, 2021)
- Form of Employment Agreement with Jon Garfield (Filed With SEC on November 29, 2021)
- Exclusive License Agreement between the Registrant and St. Jude Childrens Research Hospital, Inc., effective as of January 27, 2020 (Filed With SEC on November 29, 2021)
- License Agreement between the Registrant and Oxford University Innovation Limited, effective as of July16, 2019 (Filed With SEC on November 29, 2021)
- Exclusive License Agreement between the Registrant and Childrens Hospital Medical Center, d/b/a Cincinnati Childrens Hospital Medical Center, effective as of June 1, 2021 (Filed With SEC on November 29, 2021)
- License Agreement between the Registrant and Oxford University Innovation Limited, effective as of July16, 2019 (Filed With SEC on November 5, 2021)
- Specimen Common Stock Certificate (Filed With SEC on November 5, 2021)
- Exclusive License Agreement between the Registrant and Childrens Hospital Medical Center, d/b/a Cincinnati Childrens Hospital Medical Center, effective as of June 1, 2021 (Filed With SEC on November 5, 2021)
- Exclusive License Agreement between the Registrant and St. Jude Childrens Research Hospital, Inc., effective as of January 27, 2020 (Filed With SEC on November 5, 2021)
- 2021 Equity Incentive Plan (Filed With SEC on October 8, 2021)
- 2019 Equity Incentive Plan Form of Stock Option Grant Agreement (Filed With SEC on October 8, 2021)
- 2021 Equity Incentive Plan Form of Incentive Stock Option Agreement (Employee) (Filed With SEC on October 8, 2021)
- 2021 Equity Incentive Plan Form of Nonstatuory Stock Option Agreeement (Consultant) (Filed With SEC on October 8, 2021)
- 2021 Equity Incentive Plan Form of Nonstatuory Stock Option Agreeement (Non-Employee Director) (Filed With SEC on October 8, 2021)
- 2021 Equity Incentive Plan Form of Nonstatuory Stock Option Agreeement (Employee) (Filed With SEC on October 8, 2021)
- Lease Agreement, dated as of April 29, 2021, between the Registrant and Regus Management Group, LLC (Filed With SEC on October 8, 2021)
- Master Services Agreement between the Registrant and Ology Bioservices, Inc., effective as of July 19, 2019 (Filed With SEC on October 8, 2021)
- Project Addendum 1 to Master Services Agreement between the Registrant and Ology Bioservices, Inc., effective as of October 9, 2019 (Filed With SEC on October 8, 2021)
- Letter Agreement between the Registrant and Ology Bioservices, Inc., dated as of January 9, 2020 (Filed With SEC on October 8, 2021)
- Project Addendum II to Master Services Agreement between the Registrant and Ology Bioservices, Inc., effective as of May 21, 2021 (Filed With SEC on October 8, 2021)
- Form of Employment Agreement with Joseph Hernandez (Filed With SEC on October 8, 2021)
- Form of Employment Agreement with Erin Henderson (Filed With SEC on October 8, 2021)
- Form of Indemnification Agreement for Directors and Officers (Filed With SEC on October 8, 2021)
- 2019 Equity Incentive Plan (Filed With SEC on October 8, 2021)
